-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LEZG7OKEzxojCPIZNU8E8AgXdLY4au4rOR4w9TdXZoXP0KsEwGJFggCZYPNn1LNa bxekEFm6ZAqol/dWCuh/bQ== 0001017951-02-000035.txt : 20020414 0001017951-02-000035.hdr.sgml : 20020414 ACCESSION NUMBER: 0001017951-02-000035 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020211 GROUP MEMBERS: COLUMBINE VENTURE FUND II, L.P. GROUP MEMBERS: COLUMBINE VENTURE MANAGEMENT II GROUP MEMBERS: SHERMAN J. MULLER GROUP MEMBERS: TERENCE E. WINTERS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COLLAGENEX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012270 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521758016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-47825 FILM NUMBER: 02532871 BUSINESS ADDRESS: STREET 1: 41 UNIVERSITY DRIVE CITY: NEWTON STATE: PA ZIP: 18940 BUSINESS PHONE: 2155797388 MAIL ADDRESS: STREET 1: 41 UNIVERSITY DRIVE CITY: NEWTON STATE: PA ZIP: 18940 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: COLUMBINE VENTURE FUND II LP /DE/ CENTRAL INDEX KEY: 0001055611 IRS NUMBER: 841090581 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 5460 S QUEBEC ST STREET 2: STE 270 CITY: ENGLEWOOD STATE: CO ZIP: 80111 BUSINESS PHONE: 3035928344 MAIL ADDRESS: STREET 1: 5460 S QUEBEC ST STREET 2: STE 270 CITY: ENGLEWOOD STATE: CO ZIP: 80111 SC 13G/A 1 g131201.txt AMENDMENT NO. 5 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* COLLAGENEX PHARMACEUTICALS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 19419B-10-0 (CUSIP Number) December 31, 2001 (Annual Filing) (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 19419B-10-0 13G Page 2 of 8 NAMES OF REPORTING PERSONS. 1. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Columbine Venture Fund II, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA 5. SOLE VOTING POWER NUMBER OF 74,941 SHARES BENE- 6. SHARED VOTING POWER FICIALLY OWNED 7. SOLE DISPOSITIVE POWER BY EACH REPORTING 74,941 PERSON 8. SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 74,941 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) .7% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN CUSIP NO. 19419B-10-0 13G Page 3 of 8 NAMES OF REPORTING PERSONS. 1. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Columbine Venture Management II 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA 5. SOLE VOTING POWER NUMBER OF 197,047 SHARES BENE- 6. SHARED VOTING POWER FICIALLY OWNED 7. SOLE DISPOSITIVE POWER BY EACH REPORTING 197,047 PERSON 8. SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 197,047 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.8% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN CUSIP NO. 19419B-10-0 13G Page 4 of 8 NAMES OF REPORTING PERSONS. 1. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Sherman J. Muller 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA 5. SOLE VOTING POWER NUMBER OF 6. SHARED VOTING POWER SHARES BENE- 197,047 FICIALLY OWNED 7. SOLE DISPOSITIVE POWER BY EACH REPORTING 8. SHARED DISPOSITIVE POWER PERSON 197,047 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 197,047 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.8% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN CUSIP NO. 19419B-10-0 13G Page 5 of 8 NAMES OF REPORTING PERSONS. 1. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Terence E. Winters 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA 5. SOLE VOTING POWER NUMBER OF 6. SHARED VOTING POWER SHARES BENE- 197,047 FICIALLY OWNED 7. SOLE DISPOSITIVE POWER BY EACH REPORTING 8. SHARED DISPOSITIVE POWER PERSON 197,047 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 197,047 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.8% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN CUSIP NO. 19419B-10-0 13G Page 6 of 8 Item 1: Collagenex Pharmaceuticals, Inc. 41 University Drive Newton, Pennsylvania 18940 Item 2: (a) Columbine Venture Fund II, L.P. (b) 7000 E. Belleview Avenue, Suite 150 Englewood, Colorado 80111 (c) Delaware, USA (d) Common Stock (e) CUSIP No. 19419B-10-0 (a) Columbine Venture Management II (b) 7000 E. Belleview Avenue, Suite 150 Englewood, Colorado 80111 (c) Delaware, USA (d) Common Stock (e) CUSIP No. 19419B-10-0 (a) Sherman J. Muller (b) 7000 E. Belleview Avenue, Suite 150 Englewood, Colorado 80111 (c) USA (d) Common Stock (e) CUSIP No. 19419B-10-0 (a) Terence E. Winters (b) 10040 East Happy Valley Road, No. 366 Scottsdale, Arizona 85255 (c) USA (d) Common Stock (e) CUSIP No. 19419B-10-0 CUSIP NO. 19419B-10-0 13G Page 7 of 8 Item 3: Not applicable. Item 4: Reporting Persons incorporate by reference the information on ownership contained under numbers 5, 6, 7, 8, 9, 10 and 11 of the cover sheets. The numbers include 172,047 shares of Common Stock and options to purchase 25,000 shares of Common Stock that are now exercisable. Title to 49,941 shares of Common Stock is held by Columbine Venture Fund II, L.P. ("Columbine") which does not hold an interest in 122,106 shares of Common Stock, title to which is held by Columbine Venture Management II ("Management"). Management is the sole general partner of Columbine and is a reporting person with respect to the shares held by Columbine by virtue of its voting power and dispositive power over the shares held by Columbine. The individuals are general partners in Columbine Venture Management II, and each is a reporting person with respect to the shares held by Columbine and Management by virtue of his shared voting and dispositive power over the shares held by Columbine in which he is a general partner of the general partner and Management in which he is a general partner. Each reporting person, other than Columbine, disclaims his or its interest in the Common Stock, except to the extent of his or its proportionate interest as a partner. Item No. 5: Ownership of 5 Percent or Less as a Class: If this statement is being filed to report the fact that, as of the date hereof, each reporting person has ceased to be the beneficial owner of more than 5 Percent of the class of securities, check the following: [X] - Item No. 6: No person, other than the reporting person, has a right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities. Item 7: Not applicable. Item 8: Not applicable. Item 9: Not applicable. CUSIP NO. 19419B-10-0 13G Page 8 of 8 Item 10: Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 11, 2002 /s/ JAMES A. JACOBSON -------------------------------- James A. Jacobson, as agent and attorney-in-fact for each reporting person pursuant to powers of attorney attached hereto -----END PRIVACY-ENHANCED MESSAGE-----